Brief: Diasorin, Fy Adjusted EBITDA Eur 394 Mln
March 14 (Reuters) - DiaSorin SpA DIAS.MI: FY REVENUE EUR 1.2 BILLION FY ADJUSTED EBITDA EUR 394 MILLION FY NET PROFIT EUR 187 MILLION SEES 2025 ADJUSTED EBITDA MARGIN AT AROUND 34% SEES 2025 REVENUE EX COVID AT AROUND +8% PROPOSES DIVIDEND OF EUR 1.20 PER SHARE Further company coverage: DIAS.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21